Literature DB >> 30237272

Clinical and molecular features of acute promyelocytic leukemia with variant retinoid acid receptor fusions.

Lijun Wen1, Yang Xu1, Li Yao1, Nana Wang1, Qinrong Wang1, Tianhui Liu2, Jinlan Pan1, Jiannong Cen1, Huifeng Zhou1, Miao Miao1, Yang W Shao3,4,5, Xiaonan Wang5, Xiaoxia Wang5, Changgeng Ruan1, Depei Wu1,2, Suning Chen6,2.   

Abstract

Entities:  

Year:  2018        PMID： 30237272      PMCID： PMC6518904          DOI： 10.3324/haematol.2018.205369

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

Review 1.  Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia.

Authors:  A Melnick; J D Licht
Journal:  Blood       Date:  1999-05-15       Impact factor: 22.113

2.  Genomic Classification and Prognosis in Acute Myeloid Leukemia.

Authors:  Elli Papaemmanuil; Moritz Gerstung; Hartmut Döhner; Peter J Campbell; Lars Bullinger; Verena I Gaidzik; Peter Paschka; Nicola D Roberts; Nicola E Potter; Michael Heuser; Felicitas Thol; Niccolo Bolli; Gunes Gundem; Peter Van Loo; Inigo Martincorena; Peter Ganly; Laura Mudie; Stuart McLaren; Sarah O'Meara; Keiran Raine; David R Jones; Jon W Teague; Adam P Butler; Mel F Greaves; Arnold Ganser; Konstanze Döhner; Richard F Schlenk
Journal:  N Engl J Med       Date:  2016-06-09       Impact factor: 91.245

3.  Identification of novel recurrent STAT3-RARA fusions in acute promyelocytic leukemia lacking t(15;17)(q22;q12)/PML-RARA.

Authors:  Li Yao; Lijun Wen; Nana Wang; Tianhui Liu; Yang Xu; Changgeng Ruan; Depei Wu; Suning Chen
Journal:  Blood       Date:  2017-12-13       Impact factor: 22.113

4.  Identification of novel recurrent CPSF6-RARG fusions in acute myeloid leukemia resembling acute promyelocytic leukemia.

Authors:  Tianhui Liu; Lijun Wen; Hongjian Yuan; Yi Wang; Li Yao; Yang Xu; Jiannong Cen; Changgeng Ruan; Depei Wu; Suning Chen
Journal:  Blood       Date:  2018-02-27       Impact factor: 22.113

5.  Mutations affecting both the rearranged and the unrearranged PML alleles in refractory acute promyelocytic leukaemia.

Authors:  Licia Iaccarino; Tiziana Ottone; Mariadomenica Divona; Laura Cicconi; Roberto Cairoli; Maria Teresa Voso; Francesco Lo-Coco
Journal:  Br J Haematol       Date:  2016-01-05       Impact factor: 6.998

6.  A novel NUP98/RARG gene fusion in acute myeloid leukemia resembling acute promyelocytic leukemia.

Authors:  Esperanza Such; José Cervera; Ana Valencia; Eva Barragán; Mariam Ibañez; Irene Luna; Oscar Fuster; Maria Luz Perez-Sirvent; Leonor Senent; Amparo Sempere; Jesús Martinez; Guillermo Martín-Aragonés; Miguel A Sanz
Journal:  Blood       Date:  2010-10-08       Impact factor: 22.113

7.  Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Groupe Français de Cytogénétique Hématologique, Groupe de Français d'Hematologie Cellulaire, UK Cancer Cytogenetics Group and BIOMED 1 European Community-Concerted Action "Molecular Cytogenetic Diagnosis in Haematological Malignancies".

Authors:  D Grimwade; A Biondi; M J Mozziconacci; A Hagemeijer; R Berger; M Neat; K Howe; N Dastugue; J Jansen; I Radford-Weiss; F Lo Coco; M Lessard; J M Hernandez; E Delabesse; D Head; V Liso; D Sainty; G Flandrin; E Solomon; F Birg; M Lafage-Pochitaloff
Journal:  Blood       Date:  2000-08-15       Impact factor: 22.113

8.  The PRKAR1A gene is fused to RARA in a new variant acute promyelocytic leukemia.

Authors:  Alberto Catalano; Mark A Dawson; Karthiga Somana; Stephen Opat; Anthony Schwarer; Lynda J Campbell; Harry Iland
Journal:  Blood       Date:  2007-08-21       Impact factor: 22.113

9.  The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR.

Authors:  H de Thé; C Lavau; A Marchio; C Chomienne; L Degos; A Dejean
Journal:  Cell       Date:  1991-08-23       Impact factor: 41.582

10.  Varying responses of PML-RARA with different genetic mutations to arsenic trioxide.

Authors:  Jiangying Liu; Hong-Hu Zhu; Hao Jiang; Qian Jiang; Xiao-Jun Huang
Journal:  Blood       Date:  2015-11-04       Impact factor: 22.113
View more
  8 in total

Review 1.  Current views on the genetic landscape and management of variant acute promyelocytic leukemia.

Authors:  Xiang Zhang; Jiewen Sun; Wenjuan Yu; Jie Jin
Journal:  Biomark Res       Date:  2021-05-06

2.  Arsenic trioxide induces proteasome dependent TBLR1-RARα degradation to improve leukemia eradication through cell differentiation enhancement.

Authors:  Yirui Chen; Manning Li; Han Wu; Shijin Yuan; Yan Xia; Yingjian Wang; Ye Peng; Jianping Lan; Yanzhong Wang
Journal:  J Cancer       Date:  2022-04-18       Impact factor: 4.478

Review 3.  RARG Gene Dysregulation in Acute Myeloid Leukemia.

Authors:  Maria Rosa Conserva; Immacolata Redavid; Luisa Anelli; Antonella Zagaria; Giorgina Specchia; Francesco Albano
Journal:  Front Mol Biosci       Date:  2019-10-24

Review 4.  Atypical Rearrangements in APL-Like Acute Myeloid Leukemias: Molecular Characterization and Prognosis.

Authors:  Luca Guarnera; Tiziana Ottone; Emiliano Fabiani; Mariadomenica Divona; Arianna Savi; Serena Travaglini; Giulia Falconi; Paola Panetta; Maria Cristina Rapanotti; Maria Teresa Voso
Journal:  Front Oncol       Date:  2022-04-12       Impact factor: 5.738

5.  Targeted Protein Degradation: An Important Tool for Drug Discovery for "Undruggable" Tumor Transcription Factors.

Authors:  Mengyuan Dai; Sridhar Radhakrishnan; Rui Li; Ruirong Tan; Kuo Yan; Gang Fan; Miao Liu
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

6.  Treatment of STAT5b-RARA positive acute promyelocytic leukemia by Venetoclax combining with homoharringtonine, cytarabine: A case report and literature review.

Authors:  Guangji Zhang; Yang Song; Li Wan; Kaiqi Liu; Shaowei Qiu; Jianxiang Wang; Yingchang Mi
Journal:  Blood Sci       Date:  2022-05-17

7.  Tumor suppressor function of Gata2 in acute promyelocytic leukemia.

Authors:  Casey D S Katerndahl; Olivia R S Rogers; Ryan B Day; Michelle A Cai; Timothy P Rooney; Nichole M Helton; Mieke Hoock; Sai Mukund Ramakrishnan; Sridhar Nonavinkere Srivatsan; Lukas D Wartman; Christopher A Miller; Timothy J Ley
Journal:  Blood       Date:  2021-09-30       Impact factor: 25.476

8.  Alkaloid-based regimen is beneficial for acute myeloid leukemia resembling acute promyelocytic leukemia with NUP98/RARG fusion and RUNX1 mutation: A case report.

Authors:  Wei Wei; Qiuju Liu; Fei Song; He Cao; Mengmeng Liu; Yan Jiang; Yanchun Li; Sujun Gao
Journal:  Medicine (Baltimore)       Date:  2020-10-02       Impact factor: 1.817
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.